Memantine improves L-dopa induced dyskinesias

被引：0
|
作者：
Varanese, S.
Howard, J.
Di Rocco, A.
机构：
来源：
MOVEMENT DISORDERS | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S360 / S360
页数：1
相关论文
共 50 条
  • [21] Can serotoninergic antidepressants prevent or delay the development of L-dopa induced dyskinesias in PD patients?
    Mazzucchi, S.
    Frosini, D.
    Unti, E.
    Del Prete, E.
    Del Gamba, C.
    Bonuccelli, U.
    Ceravolo, R.
    MOVEMENT DISORDERS, 2013, 28 : S217 - S217
  • [22] Electrical neuroinhibition of CMPf is effective on tremor and L-Dopa induced dyskinesias in Parkinson's disease
    Benabid, AL
    Blond, S
    Pollak, P
    CaparrosLefebvre, D
    NEUROLOGY, 1997, 48 (03) : 53003 - 53003
  • [23] Mirtazapine in L-dopa-induced dyskinesias
    Meco, G
    Fabrizio, E
    Di Rezze, S
    Alessandri, A
    Pratesi, L
    CLINICAL NEUROPHARMACOLOGY, 2003, 26 (04) : 179 - 181
  • [24] Pathophysiology of L-dopa-induced dyskinesias
    Bédard, PJ
    Blanchet, PJ
    Lévesque, D
    Soghomonian, JJ
    Grondin, R
    Morissette, M
    Goulet, M
    Calon, F
    Falardeau, P
    Gomez-Mancilla, B
    Doucet, JP
    Robertson, GS
    DiPaolo, T
    MOVEMENT DISORDERS, 1999, 14 : 4 - 8
  • [25] Analysis of structural plastic changes underlying L-DOPA induced dyskinesias in an animal model of parkinsonism
    Taravini, I.
    Suarez, L. M.
    Gomez, G.
    Escande, M.
    Rela, L.
    Moratalla, R.
    Murer, G.
    Gershanik, O.
    MOVEMENT DISORDERS, 2013, 28 : S379 - S379
  • [26] L-DOPA INDUCED DYSKINESIA
    Tursunov, D.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E94 - E94
  • [27] Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys
    Grondin, R
    Tahar, AH
    Doan, VD
    Ladure, P
    Bédard, PJ
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 361 (02) : 181 - 186
  • [28] Mirtazapine in L-dopa-induced dyskinesias
    Fabrizio, E
    Vanacore, N
    Pratesi, L
    Di Rezze, S
    Alessandri, A
    Meco, G
    MOVEMENT DISORDERS, 2002, 17 : S107 - S107
  • [29] DYSKINESIAS WITH RESPECT TO INITIATION AND TERMINATION OF L-DOPA ADMINISTRATION - CONSIDERATION OF DOSAGE
    LHERMITTE, F
    AGID, Y
    SIGNORET, JL
    STUDLER, JM
    REVUE NEUROLOGIQUE, 1976, 132 (12) : 876 - 876
  • [30] Noradrenoceptor antagonism with idazoxan improves l-dopa-induced dyskinesias in MPTP monkeys
    R. Grondin
    Abdallah Hadj Tahar
    Van Diep Doan
    P. Ladure
    P.J. Bédard
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2000, 361 : 181 - 186
12345